Prot #PCYC-1145-LT: Extended treatment protocol for subjects continuing to benefit from ibrutinib after completion of ibrutinib clinical trials

Project: Research project

Project Details

StatusActive
Effective start/end date9/1/179/30/20

Funding

  • Quintiles Transnational Holdings Inc. (Prot #PCYC-1145-LT)
  • Pharmacyclics, Inc. (Prot #PCYC-1145-LT)